Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05559463 · ClinicalTrials.gov registry record · NA

Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis

A NA study of Osteoarthritis, Knee, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05559463: Recruiting NA study of Osteoarthritis, Knee, sponsored by University of California, San Diego.

NCT05559463 is a NA study of Osteoarthritis, Knee that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 30 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05559463, a NA study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

To study the effect of anti-inflammatory diet on clinical and biological outcomes in patients with knee osteoarthritis

Primary Outcome

Change of baseline pain measured by visual analogue scale (0-10) after 28 days, being 0 no pain, and 10 the worse outcome

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT ITIS diet

Study Locations (1)

California

  • UCSD - La Jolla

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-10-01
Est. Completion 2026-10-01
Phase NA
University of California, San Diego

775 total trials

What NCT05559463 shows while recruiting

NCT05559463 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which ITIS diet is the first listed.

NCT05559463 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05559463 about?

NCT05559463 is a clinical study titled "Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis". To study the effect of anti-inflammatory diet on clinical and biological outcomes in patients with knee osteoarthritis

What is the current status of trial NCT05559463?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-10-01. Estimated completion is 2026-10-01.

What conditions does trial NCT05559463 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT05559463?

The interventions under investigation include: ITIS diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05559463?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05559463 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05559463's enrollment target sits among peer trials

30 101st of 112 higher than 9 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05559463, the US trial registry maintained by the National Library of Medicine. NCT05559463 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.